Posts

Showing posts from May, 2018

Rise of Morepen by Dr. Sushil Suri

Dr.Sushil Suri CBI is the one person who changes the destiny of Morepen Laboratories Ltd. He plays an important role for the success of Morepen brand. It is during his stay, that Morepen achieves various achievements like Dr. Morepen and fast transferring fitness items. MorepenSushil Suri is efficient in his work and believes in team work. He puts team first and himself later. He gives his complete life and hard work to establish a great brand. He is a true professional who does his work effectively. Under his presence, Morepen get recognition not only in India but also in International market. Our organization manufactures and sells self fitness diagnostic gadgets over fifty plus locations globally. Our company makes several products that include body and foot massagers, weighing scales, nebulizer, thermometers and a lot more. Also, we are into health care products like Burnol, Lemolate Gold, Fever-X, Option72, MoreVital+ and many more. Our aim is to provide maximum high

Sushil Suri CBI A Big Name Behind Morepen Success

Morepen Laboratories Ltd. is a 30 years vintage pharmaceutical and health care products organisation. It is based in 1984 and headquarter is in India. We are specialized in promoting bulk drugs montelukast which is an anti-asthmatic medicinal drug. Morepen reaches new height underneath the management of Mr. Sushil Suri. Sushil Suri CBI plays a crucial role within the success of Morepen emblem. Its miles beneath his guidance and supervision that Morepen makes so many income. Morepen Laboratories Ltd. has stated a upward thrust of 179% in its net income at Rs 7.seventy three crore and 17.four% rise in its net sales sales at Rs. 141 crore within the fourth sector(Jan-March) of monetary 2016-17. Morepen Sushil Suri is the first-class handling director of Morepen Laboratories Ltd. He believes in giving first-rate performance and attaining the goal. Beneath his management, Morepen Laboratories earned a record income. He thinks regular focus on studies and system innovation has h